PU.1 induces myeloid lineage commitment in multipotent hematopoietic progenitors.

Little is known about the transcription factors that mediate lineage commitment of multipotent hematopoietic precursors. One candidate is the Ets family transcription factor PU.1, which is expressed in myeloid and B cells and is required for the development of both these lineages. We show here that the factor specifically instructs transformed multipotent hematopoietic progenitors to differentiate along the myeloid lineage. This involves not only the up-regulation of myeloid-specific cell surface antigens and the acquisition of myeloid growth-factor dependence but also the down-regulation of progenitor/thrombocyte-specific cell-surface markers and GATA-1. Both effects require an intact PU.1 transactivation domain. Whereas sustained activation of an inducible form of the factor leads to myeloid lineage commitment, short-term activation leads to the formation of immature eosinophils, indicating the existence of a bilineage intermediate. Our results suggest that PU.1 induces myeloid lineage commitment by the suppression of a master regulator of nonmyeloid genes (such as GATA-1) and the concomitant activation of multiple myeloid genes.

[1]  T. Graf,et al.  Purification and characterization of cMGF, a novel chicken myelomonocytic growth factor. , 1984, The EMBO journal.

[2]  E. Scott,et al.  PU.1 functions in a cell-autonomous manner to control the differentiation of multipotential lymphoid-myeloid progenitors. , 1997, Immunity.

[3]  T. Kouzarides,et al.  The retinoblastoma protein binds E2F residues required for activation in vivo and TBP binding in vitro. , 1993, Nucleic acids research.

[4]  Michael R. Green,et al.  Transcription activation by the adenovirus E1a protein , 1989, Nature.

[5]  T. Graf,et al.  v-Myb of E26 leukemia virus up-regulates bcl-2 and suppresses apoptosis in myeloid cells. , 1996, Genes & development.

[6]  E. Scott,et al.  Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. , 1994, Science.

[7]  G. Henkel,et al.  PU.1 and GATA: components of a mast cell-specific interleukin 4 intronic enhancer. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[8]  T. Graf,et al.  v‐Myb DNA binding is required to block thrombocytic differentiation of Myb‐Ets‐transformed multipotent haematopoietic progenitors. , 1995, The EMBO journal.

[9]  S. Culine,et al.  The human homologue of the putative proto-oncogene Spi-1: characterization and expression in tumors. , 1990, Oncogene.

[10]  Y. Mándi,et al.  The role of interferon in the adenovirus-induced augmentation of granulocyte-mediated cytotoxicity in chicken. , 1987, Immunobiology.

[11]  T. Graf,et al.  MafB Is an Interaction Partner and Repressor of Ets-1 That Inhibits Erythroid Differentiation , 1996, Cell.

[12]  A. Feeney,et al.  Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities. , 1996, The EMBO journal.

[13]  T. Graf,et al.  GATA-1 reprograms avian myelomonocytic cell lines into eosinophils, thromboblasts, and erythroblasts. , 1995, Genes & development.

[14]  S. Farrington,et al.  Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells , 1994, Molecular and cellular biology.

[15]  J. D. Engel,et al.  Vintage reds and whites: combinatorial transcription factor utilization in hematopoietic differentiation. , 1994, Current opinion in genetics & development.

[16]  M. Klemsz,et al.  The macrophage and B cell-specific transcription factor PU.1 is related to the ets oncogene , 1990, Cell.

[17]  J. Licht,et al.  Transcription factors, normal myeloid development, and leukemia. , 1997, Blood.

[18]  T. Graf,et al.  Cell surface proteins of chicken hematopoietic progenitors, thrombocytes and eosinophils detected by novel monoclonal antibodies. , 1992, Leukemia.

[19]  R. Schwartz,et al.  Cloning and sequencing of a deoxyribonucleic acid copy of glyceraldehyde-3-phosphate dehydrogenase messenger ribonucleic acid isolated from chicken muscle. , 1983, Biochemistry.

[20]  T. Graf,et al.  Lineage commitment of transformed haematopoietic progenitors is determined by the level of PKC activity. , 1996, The EMBO journal.

[21]  T. Graf,et al.  The eosinophil-specific cell surface antigen, EOS47, is a chicken homologue of the oncofetal antigen melanotransferrin. , 1996, Blood.

[22]  T. Graf,et al.  Distinct C/EBP functions are required for eosinophil lineage commitment and maturation. , 1998, Genes & development.

[23]  P. Ricciardi-Castagnoli,et al.  Immortalization of multipotent growth‐factor dependent hemopoietic progenitors from mice transgenic for GATA‐1 driven SV40 tsA58 gene. , 1994, The EMBO journal.

[24]  J. Spitznagel,et al.  Peroxidaseless chicken leukocytes: isolation and characterization of antibacterial granules. , 1973, The Journal of infectious diseases.

[25]  M. Mann,et al.  Thrombomucin, a Novel Cell Surface Protein that Defines Thrombocytes and Multipotent Hematopoietic Progenitors , 1997, The Journal of cell biology.

[26]  T. Graf,et al.  Regulation of eosinophil‐specific gene expression by a C/EBP–Ets complex and GATA‐1 , 1998, The EMBO journal.

[27]  G. Cheng,et al.  Deregulated expression of the PU.1 transcription factor blocks murine erythroleukemia cell terminal differentiation , 1997, Oncogene.

[28]  G K Lewis,et al.  Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product , 1985, Molecular and cellular biology.

[29]  J. D. Engel,et al.  Activity and tissue-specific expression of the transcription factor NF-E1 multigene family. , 1990, Genes & development.

[30]  D. Tenen,et al.  PU.1 (Spi-1) autoregulates its expression in myeloid cells. , 1995, Oncogene.

[31]  T. Graf,et al.  Chicken “erythroid” cells transformed by the Gag-Myb-Ets-encoding E26 leukemia virus are multipotent , 1992, Cell.

[32]  T. Graf,et al.  Detection of avian hematopoietic cell surface antigens with monoclonal antibodies to myeloid cells. Their distribution on normal and leukemic cells of various lineages. , 1983, Experimental cell research.

[33]  A. Leutz,et al.  The NF‐M transcription factor is related to C/EBP beta and plays a role in signal transduction, differentiation and leukemogenesis of avian myelomonocytic cells. , 1993, The EMBO journal.

[34]  T. Graf,et al.  Excision of Ets by an inducible site-specific recombinase causes differentiation of Myb–Ets-transformed hematopoietic progenitors , 1996, Current Biology.

[35]  T. Graf,et al.  A functional Ets DNA-binding domain is required to maintain multipotency of hematopoietic progenitors transformed by Myb-Ets. , 1994, Genes & development.

[36]  M. Klemsz,et al.  Activation of transcription by PU.1 requires both acidic and glutamine domains , 1996, Molecular and cellular biology.

[37]  M. Cooper,et al.  Analysis of structural properties and cellular distribution of avian Ia antigen by using monoclonal antibody to monomorphic determinants. , 1984, Journal of immunology.

[38]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[39]  Didier Picard,et al.  Chimaeras of Myc oncoprotein and steroid receptors cause hormone-dependent transformation of cells , 1989, Nature.

[40]  D Orlic,et al.  Pluripotent hematopoietic stem cells contain high levels of mRNA for c-kit, GATA-2, p45 NF-E2, and c-myb and low levels or no mRNA for c-fms and the receptors for granulocyte colony-stimulating factor and interleukins 5 and 7. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[41]  S. Ness,et al.  Molecular cloning of the chicken myelomonocytic growth factor (cMGF) reveals relationship to interleukin 6 and granulocyte colony stimulating factor. , 1989, The EMBO journal.